Repeated white light transurethral resection of the bladder in nonmuscle-invasive urothelial bladder cancers: Systematic review and meta-analysis

Journal of Endourology

Volumn 25, Issue 11, 2011, Pages 1703-1712

  Vianello, Alberto ^a   Costantini, Elisabetta ^a   Del Zingaro, Michele ^a   Bini, Vittorio ^a   Herr, Harry W ^b   Porena, Massimo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CYSTECTOMY; DISEASE COURSE; HUMAN; META ANALYSIS; NONMUSCLE INVASIVE BLADDER CANCER; PREVALENCE; PRIORITY JOURNAL; REVIEW; SECOND LOOK SURGERY; SYSTEMATIC REVIEW; TRANSURETHRAL BLADDER RESECTION;

HUMANS; LIGHT; MUSCLES; NEOPLASM GRADING; PREVALENCE; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES;

EID: 80855131047     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2011.0081     Document Type: Review

References (50)

1. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. In: IARC CancerBase 2004 ed. Lyon, France: IARC Press, vol 5, version 2.0, 2004.
2. Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: Epidemiology, staging and grading, and diagnosis. Urology 2005;66 (suppl 1):4-34. (Pubitemid 43049607)
3. Murta-Nascimento C, Schmitz-Dräger BJ, Zeegers MP, et al. Epidemiology of urinary bladder cancer: From tumor development to patient's death. World J Urol 2007;25:285-295.
4. Fleshner NE, Herr HW, Stewart AK, et al. The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1996;78:1505-1513.
5. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435-1448. (Pubitemid 28550639)
6. Sauter G, Algaba F, Amin M, et al, eds. Tumours of the urinary system: Non-invasive urothelial neoplasias. WHO Classification of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press, 2004.
7. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours. 6th ed. New York: Wiley-Liss, 2002.
8. Brausi M, Collette L, Kurth K, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol 2002; 41:523-531.
9. Sedelaar JP, Witjes JA. Technique of TUR of bladder tumours: Value of repeated TUR and random biopsies. Eur Urol Update Series 2007;5:139.
10. Sivalingam S, Probert JL, Schwaibold H. The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer. BJU Int 3005;96: 759-762.
11. Hall MC, Chang SS, Dalbagni G, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 2007;178:2314-2330. (Pubitemid 350080987)
12. Thomas K, O'Brien T. Improving transurethral resection of bladder tumour: The gold standard for diagnosis and treatment of bladder tumours. Eur Urol 2008;(suppl 7):524.
13. Jocham D, Stepp H, Waidelich R. Photodynamic diagnosis in urology: State-of-the-art. Eur Urol 2008;53:1138-1148.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188. (Pubitemid 17189972)
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560. (Pubitemid 37088507)
16. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50: 1088-1101.
17. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-634. (Pubitemid 27387172)
18. Tobias A. Assessing the influences of a single study in meta-analysis. Stata Tech Bull 1999;47:15.
19. Bouchot O, Rigaud J, Karam G, et al. The value of a second transurethral resection in evaluating patients with T1 bladder tumours. Eur Urol 2001;39:120.
20. Brauers A, Buettner R, Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer: Is cy-stectomy often too early? J Urol 2001;165:808-810. (Pubitemid 32156283)
21. Divrik T, Yildirim U, Eroglu AS, et al. Is a second transur-ethral resection necessary for newly diagnosed pT1 bladder cancer? J Urol 2006;175:1258-1261.
22. Engelhardt PF, Riedl CR, Pflüger H. Is a second look tur-b in patients with superficial bladder cancer necessary? J En-dourol 1998;12 (suppl 2):S164.
23. Geavlete P, Jora T, Georgescu D, Nita G. Value of a second tur in bladder tumours evaluation and treatment. Eur Urol 2002;suppl;2:120.
24. Giulianelli R, Brunori S, Gentile BC, et al. The predictive role of the re-TURB in the evaluation of high-grade disease progression rate of the T1G3 bladder neoplasm. J Endourol 2007;21:A6.
25. Grimm MO, Steinhoff C, Simon X, et al. Effect of routine repeat transurethral resection for superficial bladder cancer: A long-term observational study. J Urol 2003;170:433-437. (Pubitemid 36870218)
26. Han KS, Joung JY, Cho KS, et al. Results of repeated trans-urethral resection for a second opinion in patients referred for nonmuscle invasive bladder cancer: The referral cancer center experience and review of the literature. J Endourol 2008;22:2699-2704.
27. Herr HW, Donat SM. A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU Int 2006;97:1194-1198. (Pubitemid 43907320)
28. Herr HW, Donat SM, Dalbagni G. Can restaging transure-thral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol 2007;177:75-79. (Pubitemid 44879466)
29. Mersdorf A, Brauers A, Wolff JM, et al. 2nd Tur for superficial bladder cancer: A must? J Urol 1998;159:143.
30. Sanseverino R, Campitelli A, Napodano G, et al. Prognostic value of Re-TURB of high risk non invasive bladder cancer. J Urol 2008;179:514.
31. Schips L, Augustin H, Zigeuner RE, et al. Is repeated trans-urethral resection justified in patients with newly diagnosed superficial bladder cancer? Urology 2002;59:220-223. (Pubitemid 34134518)
32. Schwaibold HE, Sivalingam S, May F, et al. The value of a second transurethral resection for T1 bladder cancer. BJU Int 2006;97:1199-1201. (Pubitemid 43907321)
33. Zurkirchen MA, Sulser T, Gaspert A, Hauri D. Second transurethral resection of superficial transitional cell carcinoma of the bladder: A must even for experienced urologists. Urol Int 2004;72:99-102. (Pubitemid 38223792)
34. Vögeli TA, Grimm MO, Ackermann R. Prospective study for quality control of TUR of bladder tumors by routine 2nd TUR (ReTUR). J Urol 1998;159:143.
35. Zurkirchen MA, Sulser T, Hauri D. Can a second resection be omitted in the treatment of superficial bladder cancer? Eur Urol 2001;39:119.
36. Schwaibold H, Treiber U, Kubler H, et al. Significance of 2nd transurethral resection for T1 bladder cancer. Eur Urol 2000;37:111.
37. Jakse G, Algaba F, Malmstrom PU, et al. A second-look TUR in T1 transitional cell carcinoma: why? Eur Urol 2004;45:539.
38. Oosterlinck W, Lobel B, Jakse G, et al. Guidelines on bladder cancer. Eur Urol 2002;41:105-112. (Pubitemid 35428874)
39. Herr HW. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 1999;162:74-76. (Pubitemid 29420883)
40. Taguchi I, Gohji K, Hara I, et al. Clinical evaluation of random biopsy of urinary bladder in patients with superficial bladder cancer. Int J Urol 1998;5:30-34. (Pubitemid 28097227)
41. Kausch I, Sommerauer M, Montorsi F, et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: A systematic review and cumulative analysis of prospective studies. Eur Urol 2010;57:595-606.
42. Naselli A, Introini C, Bertolotto F, et al. Narrow band imaging for detecting residual/recurrent cancerous tissue during second transurethral resection of newly diagnosed non-muscle-invasive high-grade bladder cancer. BJU Int 2010; 105:208-211.
43. Bryan RT, Billingham LJ, Wallace DM. Narrow-band imaging flexible cystoscopy in the detection of recurrent ur-othelial cancer of the bladder. BJU Int 2008;101:702-706.
44. Herr H, Donat M, Dalbagni G, Taylor J. Narrow-band imaging cystoscopy to evaluate bladder tumours-individual surgeon variability. BJU Int 2010;106:53-55.
45. Babjuk M, Oosterlinck W, Sylvester R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008;54:303-314.
46. Lachand AT, Texier J, Texier P. [Surveillance and prognosis of "Ta" superficial tumors of the bladder. Homogeneous series of 138 cases followed for 1 to 18 years]. (Fre) Prog Urol 2001;11:466-471. (Pubitemid 33703886)
47. Persad R, Lammb D, Brausi M, et al. Current approaches to the management of non-muscle invasive bladder cancer: Comparison of current guidelines and recommendations. Eur Urol Suppl 2008;8 (10):637-650.
48. Millán-Rodriguez F, Chéchile-Toniolo F, Salvador-Bayarri J, et al. Multivariate analysis of prognostic factors of primary superficial bladder cancer. J Urol 2000;163:73-78.
49. Herr HW. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 2005;174:2134-2137. (Pubitemid 41611754)
50. Divrik RT, Yildirim U, Zorlu F, Ozen H. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received in-travesical mitomycin: A prospective, randomized clinical trial. J Urol 2006;175:1641-1644.